Prosecution Insights
Prosecution Insights
6 pending office actions • 4 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (33%) |
| No statute on record | 4 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BERTOGLIO, VALARIE E | 1 | 64.2% | +29.6% |
| KELLY, ROBERT M | 1 | 74.1% | +24.6% |
| VIJAYARAGHAVAN, JAGAMYA NMN | 1 | 67.7% | +39.0% |
| FOX, ALLISON M | 1 | 71.5% | +36.1% |
| SPENCE, JENNIFER SUZANNE | 1 | 65.8% | +47.7% |
| MOSS, NATALIE M | 1 | 31.2% | +17.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18080134 | HEMANGIO-COLONY FORMING CELLS | FOX, ALLISON M | 73d overdue |
| 18472176 | MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA | KELLY, ROBERT M | 58d overdue |
| 18504238 | METHODS OF PRODUCING HUMAN RPE CELLS AND PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS | BERTOGLIO, VALARIE E | 19d overdue |
| 16669931 | METHOD OF GENERATING NATURAL KILLER CELLS AND DENDRITIC CELLS FROM HUMAN EMBRYONIC STEM CELL-DERIVED HEMANGIOBLASTS | MOSS, NATALIE M | 8d |
| 18363663 | MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA | VIJAYARAGHAVAN, JAGAMYA NMN | 20d |
| 17632723 | COMPOSITIONS AND METHODS OF TREATING VASCULAR DISEASES | SPENCE, JENNIFER SUZANNE | 72d |
| Art Unit | Apps |
|---|---|
| 1633 | 3 |
| 1632 | 1 |
| 1638 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18504238 | METHODS OF PRODUCING HUMAN RPE CELLS AND PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS | BERTOGLIO, VALARIE E | 1632 | Other | Final Rejection | 19d overdue | Pending | Nov 08, 2023 |
| 18472176 | MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA | KELLY, ROBERT M | 1638 | Other | Non-Final OA | 58d overdue | Pending | Sep 21, 2023 |
| 18363663 | MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | Other | Non-Final OA | 20d | Pending | Aug 01, 2023 |
| 18080134 | HEMANGIO-COLONY FORMING CELLS | FOX, ALLISON M | 1633 | Other | Non-Final OA | 73d overdue | Pending | Dec 13, 2022 |
| 17632723 | COMPOSITIONS AND METHODS OF TREATING VASCULAR DISEASES | SPENCE, JENNIFER SUZANNE | 1633 | §103 | Non-Final OA | 72d | Pending | Feb 03, 2022 |
| 16669931 | METHOD OF GENERATING NATURAL KILLER CELLS AND DENDRITIC CELLS FROM HUMAN EMBRYONIC STEM CELL-DERIVED HEMANGIOBLASTS | MOSS, NATALIE M | 1653 | §103 | Final Rejection | 8d | Pending | Oct 31, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial